Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
1.52Price to Earnings
VS
Market
Sector
Industry
History
$ 1.01Close
$ 0.47 - $ 4.22 52-Week Range
Ticker Information
Ticker
NBYCompany Name
NOVABAY PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTNOVABAY PHARMACEUTICALS INC - Price to Earnings Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
NBY - P/E Historical data
| Date | Market Capitalization | Net Income Common Stock | Price to Earnings |
|---|---|---|---|
| 6/30/2025 | $ 3.52M | $ 2.32M | 1.52 |
| 3/31/2025 | $ 3.37M | $ 2.66M | 1.27 |
| 12/31/2024 | $ 3.33M | $ -8.61M | 0 |
| 9/30/2024 | $ 3.42M | $ -16.57M | 0 |
| 6/30/2024 | $ 2.35M | $ -16.11M | 0 |
| 3/31/2024 | $ 3.38M | $ -18.55M | 0 |
| 12/31/2023 | $ 4.18M | $ -16.7M | 0 |
| 9/30/2023 | $ 2.28M | $ -15.73M | 0 |
| 6/30/2023 | $ 3.07M | $ -19.77M | 0 |
| 3/31/2023 | $ 2.73M | $ -17.89M | 0 |
Key Performance Insights, Last 5 Years
- NOVABAY PHARMACEUTICALS INC's latest trailing twelve months (TTM) P/E stands at 0.
- Over the past 5 years, NOVABAY PHARMACEUTICALS INC's average P/E has been 1.39.
- The median P/E for NOVABAY PHARMACEUTICALS INC during this period was 1.39
- NOVABAY PHARMACEUTICALS INC reached its highest P/E over the past 5 years at 1.52.
- The lowest P/E recorded by NOVABAY PHARMACEUTICALS INC in the same timeframe 1.27
Similar metrics to P/E:
- Earnings Yield - [Calculation] The Earnings Yield, also known as the inverse of the PE ratio [PE], expresses a company’s earnings [NetIncCmn] as a percentage of [MarketCap].
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
Definition of Price to Earnings
[Calculation] Measures a company’s [MarketCap] in relation to its Net Income [NetIncCmn]. A high P/E ratio indicates that investors anticipate greater future earnings growth compared to companies with a lower P/E.Market Cap / Net Inc. Cmn.
(=) P/E P/E for NOVABAY PHARMACEUTICALS INC is calculated as follows: Market Cap [ $ 27.15M ] / Net Inc. Cmn. [ $ -12.8M ]
(=) P/E [ 0 ] NBY - Price to Earnings, Last 5 years
1.27
Minimum
Mar 31, 2025
1.52
Maximum
Jun 30, 2025
1.39
Average
1.39
Median
P/E Benchmark AnalysisMarket
The chart above depicts the distribution of P/E for companies in the Total Stock Market. The average P/E of the companies is 22.53 with a standard deviation of 13.97.
The following table provides additional summary stats:
P/E in the Market:
| filtered constituents | 2.07K |
|---|---|
| min | 0.13 |
| max | 70.11 |
| average | 22.53 |
| median | 18.89 |
| std | 13.97 |